MAHENDRA CHEMICALS
MAHENDRA CHEMICALS (India) holds 2 active US FDA Type II Drug Master Files and has DMF or CEP filings on record for 2 active ingredients. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “MAHENDRA CHEMICALS: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/mahendra-chemicals
Overview
MAHENDRA CHEMICALS is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering LIDOCAINE HYDROCHLORIDE USP; LIDOCAINE USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which MAHENDRA CHEMICALS holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
MAHENDRA CHEMICALS holds 2 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- LIDOCAINE USPActive2010-08-09
- LIDOCAINE HYDROCHLORIDE USPActive2010-08-09
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2015-07-13
FDA Warning Letter (drug product)
Is this MAHENDRA CHEMICALS?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.